Chronic Uveitis
Showing 1 - 25 of >10,000
Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate Trial in Waltham (Ixekizumab Prefilled Syringe)
Recruiting
- Uveitis, Posterior
- +3 more
- Ixekizumab Prefilled Syringe
-
Waltham, MassachusettsMassachusetts Eye Research and Surgery Institution
Oct 11, 2023
YUTIQ® 0.18 mg Intravitreal Implant for Management of Chronic
Recruiting
- Uveitis
- YUTIQ
-
Tianjin, Tianjin, ChinaTianjin Medical University Eye Hospital
Oct 23, 2022
Minocycline, Uveitis, Retinal Degeneration Trial in Guangzhou (minocycline)
Recruiting
- Minocycline
- +2 more
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Jul 24, 2022
Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)
Active, not recruiting
- Uveitis
- +2 more
- Sham Injector
- FAI Insert
-
Waltham, MassachusettsEyePoint Study Site
Dec 20, 2022
Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)
Not yet recruiting
- Uveitis
- +3 more
- Yutiq 0.18 MG Drug Implant
- Sham Injection
-
Plano, TexasTexas Retina Associates
Aug 3, 2022
Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)
Recruiting
- Uveitis, Posterior
- Fluocinolone Acetonide Intravitreal Implant 0.18 mg
-
Phoenix, Arizona
- +16 more
Aug 18, 2022
Non-infectious Uveitis Trial in Cleveland, Arlington, Houston (EYS606)
Completed
- Non-infectious Uveitis
- EYS606
-
Cleveland, Ohio
- +2 more
Mar 9, 2022
Uveitis Trial in Wroclaw (Surveillance card)
Recruiting
- Uveitis
- Surveillance card
-
Wrocław, PolandDepartment of Ophthalmology
Apr 16, 2021
Autoimmune Diseases, IBD, Crohn Disease (CD) Trial in Aabenraa, Herlev, Odense (Primary exposure variable, Other (exploratory)
Completed
- Autoimmune Diseases
- +9 more
- Primary exposure variable
- Other (exploratory) exposure variables
-
Aabenraa, Denmark
- +2 more
Jun 30, 2021
Non-Infectious Uveitis Trial in Worldwide (FAI insert, Sham injection)
Completed
- Non-Infectious Uveitis
- FAI insert
- Sham injection
-
Beverly Hills, California
- +33 more
Mar 5, 2021
Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)
Completed
- Posterior Uveitis
- +2 more
- Sham Injection
- FAI Insert
-
Hyderabad, Andhra Pradesh, India
- +14 more
Jul 10, 2020
Chronic Uveitis Trial in Worldwide (Gevokizumab)
Terminated
- Chronic Uveitis
- Gevokizumab
-
Nedlands, Australia
- +12 more
Jan 2, 2020
Juvenile Idiopathic Arthritis Associated Uveitis Trial in Cairo (biologic DMARDs)
Active, not recruiting
- Juvenile Idiopathic Arthritis Associated Uveitis
- biologic DMARDs
-
Cairo, EgyptFaculty of medicine, Cairo university
Sep 12, 2022
Imaging of Uveitis Patients Receiving Injectable Fluocinolone
Recruiting
- Uveitis
- Fluocinolone Acetonide
-
Cleveland, OhioCole Eye Institute Cleveland Clinic Foundation
Apr 27, 2022
Uveitis With Biologic Drugs in Resistant Cases
Not yet recruiting
- Uveitis
- Biologic drugs
- (no location specified)
Apr 21, 2022
Uveitis, JIA Trial in Australia, United Kingdom, United States (Adalimumab, Placebo)
Recruiting
- Uveitis
- JIA
- Adalimumab
- Placebo
-
Sacramento, California
- +24 more
Mar 9, 2022
Uveitis Trial in Miami (Norflo Oro, Placebo for Norflo Oro)
Completed
- Uveitis
- Norflo Oro
- Placebo for Norflo Oro
-
Miami, FloridaBascom Palmer Eye Institute
Mar 25, 2022
Uveitis Trial in United Kingdom
Recruiting
- Uveitis
-
Belfast, United Kingdom
- +30 more
May 19, 2022
Juvenile Idiopathic Arthritis Trial in United States (Abatacept Injection, Usual Care)
Recruiting
- Juvenile Idiopathic Arthritis
- Abatacept Injection
- Usual Care
-
Birmingham, Alabama
- +25 more
Aug 16, 2022
Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)
Terminated
- Uveitis
- +3 more
- intravitreal injection of Conbercept
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital (PUMCH)
Oct 24, 2022
Uveitis Trial in Guangzhou (Adalimumab plus Methotrexate)
Recruiting
- Uveitis
- Adalimumab plus Methotrexate
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Dec 26, 2021
Pediatric Uveitis Patients
Not yet recruiting
- Uveitis
-
Assiut, Egypt
- +1 more
Oct 1, 2023
Behçet Disease Trial in Paris (Subcutaneous Ustekinumab)
Completed
- Behçet Disease
- Subcutaneous Ustekinumab
-
Paris, FranceHôpital Cochin, Department of Internal Medicine, National Refere
Nov 19, 2021